 |
|||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||
 |
|||||||||||||||||||||||||||||||||||||||||||
|
 |
|
News |
|
|
|||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
 |
||||||||||||||||||
| March
12, 2007 BioHelix Corporation receives contract from the Department of Homeland Security to develop Next-Generation Molecular Diagnostics. |
||||||||||||||||||
| BioHelix announced today that it was awarded a Phase II contract from the Department of Homeland Security. The goal of this project is to develop next-generation molecular diagnostic assays for the rapid identification of biothreat organisms, such as Bacillus anthracis. This contract will enable BioHelix to further optimize and validate the HDA platform for use in the real-time detection of both DNA and RNA pathogens. | ||||||||||||||||||
| <<Back to News | ||||||||||||||||||
|
||
| Privacy, Limitation, Warranty, Disclaimer | ||
|
||